Fragile X chromosome syndrom – new therapy for patients
Fragile X syndrome (FXS) is the most frequent cause of inherited intellectual retardation and is also related with other psychiatric and neurologic disorders. Scientists from the University of the Basque Country and the Achucarro neurosciences centre have discovered a promising new therapy for FXS which is based on modulation of endocannabinoid system in order to alleviate symptoms. This finding has been recently published in Nature Medicine. Read full text »
















